1040 related articles for article (PubMed ID: 26022573)
1. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
2. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
3. Rift valley fever vaccines.
Ikegami T; Makino S
Vaccine; 2009 Nov; 27 Suppl 4():D69-72. PubMed ID: 19837291
[TBL] [Abstract][Full Text] [Related]
4. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Ikegami T
Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches to develop Rift Valley fever vaccines.
Indran SV; Ikegami T
Front Cell Infect Microbiol; 2012; 2():131. PubMed ID: 23112960
[TBL] [Abstract][Full Text] [Related]
6. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
[TBL] [Abstract][Full Text] [Related]
7. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel, single-cycle replicable rift valley Fever vaccine.
Murakami S; Terasaki K; Ramirez SI; Morrill JC; Makino S
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2746. PubMed ID: 24651859
[TBL] [Abstract][Full Text] [Related]
9. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.
Ly HJ; Nishiyama S; Lokugamage N; Smith JK; Zhang L; Perez D; Juelich TL; Freiberg AN; Ikegami T
Vaccine; 2017 Dec; 35(48 Pt B):6634-6642. PubMed ID: 29061350
[TBL] [Abstract][Full Text] [Related]
10. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
[TBL] [Abstract][Full Text] [Related]
12. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
[TBL] [Abstract][Full Text] [Related]
14. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
Terasaki K; Juelich TL; Smith JK; Kalveram B; Perez DD; Freiberg AN; Makino S
Sci Rep; 2018 Nov; 8(1):17097. PubMed ID: 30459418
[TBL] [Abstract][Full Text] [Related]
15. Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
Mansfield KL; Banyard AC; McElhinney L; Johnson N; Horton DL; Hernández-Triana LM; Fooks AR
Vaccine; 2015 Oct; 33(42):5520-5531. PubMed ID: 26296499
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
18. Candidate vaccines for human Rift Valley fever.
Ikegami T
Expert Opin Biol Ther; 2019 Dec; 19(12):1333-1342. PubMed ID: 31478397
[No Abstract] [Full Text] [Related]
19. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
20. Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine.
Murakami S; Terasaki K; Makino S
Methods Mol Biol; 2016; 1403():187-206. PubMed ID: 27076131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
